DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award
The summary for the DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title:
DOD POST-TRAUMATIC STRESS DISORDER IN-HOME THERAPY CLINICAL TRIAL AWARD
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility
Information not provided
The PH/TBI Research Program Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award mechanism is being offered for the first time in FY11. This Program Announcement/Funding Opportunity seeks applications for funding to support randomized controlled trial comparative effectiveness research comparing behavioral health care delivered via three distinct treatment modalities: Face-to-Face In-Office, Face-to-Face In-Home, and Tele-Behavioral Health (provider-to-in-home patient). The selected studies will employ a study design including at least three treatment arms. The target population is OIF/OEF veterans who have returned from deployment (e.g., post-deployment Active Duty Service Members, demobilized Reservists, discharged veterans) who are currently diagnosed with PTSD and have been referred for behavioral health treatment. This Program Announcement/Funding Opportunity seeks applications that will directly compare these treatment modalities across several dimensions. Proposed projects should be designed to include treatment outcome (e.g., patient symptom reduction to below diagnostic threshold) as the metric of primary importance. However, other comparisons and factors of importance include patient compliance, treatment satisfaction, optimizing patient match to treatment modality, ease of treatment delivery, provider/patient safety issues, cost, program management issues, and a resultant best practice guide to implementation.